BioSight
Companies
Veradermics, Inc logo

MANE

NYSENEW HAVEN, CT
Veradermics, Inc

Veradermics is a late-stage biopharmaceutical company developing VDPHL01, an oral extended-release formulation of minoxidil for treating androgenetic alopecia (hair loss) in men and women. The company is positioning VDPHL01 as a non-hormonal alternative designed to improve upon existing treatments by offering faster hair growth, better consistency, and fewer cardiac side effects compared to currently available options. Veradermics is currently conducting a registration-directed clinical program with pivotal trials intended to support FDA approval applications.

Price history not yet available for MANE.

Pipeline

No pipeline data on record yet.

Catalyst Calendar

No catalyst events on record for yet. Check back after the next daily ingest.

Disclaimer·BioSight aggregates publicly available data (SEC EDGAR, ClinicalTrials.gov, FDA, company press releases) and is provided as is for informational purposes only. Nothing here is investment, financial, legal, tax, or medical advice, or an offer to buy or sell any security. We make no warranty as to accuracy, completeness, or timeliness; dates and filings may contain errors or be superseded without notice; past events do not predict future outcomes. To the maximum extent permitted by law, BioSight, its operators, contributors, and affiliates disclaim all liability for any loss or damage arising from use of or reliance on this site. You are solely responsible for your own investment decisions — consult a licensed professional before acting on any information.

Unlock 12-month calendar